Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Listed
Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,019 across all filing types
Latest filing 2026-06-11 Regulatory Filings
Country US United States of America
Listing US OSUR · 10 venues

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 85% confidence The document is a Form 8-K “Current Report” filed with the U.S. SEC under the Securities Exchange Act of 1934, disclosing FDA clearance of a product. This is a regulatory compliance filing rather than an annual or quarterly financial report, earnings release, management presentation, or other specific category. It does not fit any specialized category, so it falls into the general "Regulatory Filings" (RNS) classification.
2026-06-11 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a Form 8-K “Current Report” filed pursuant to the Exchange Act. It includes Item 5.02 (changes in directors/officers), Item 5.03 (amendments to charter/bylaws) and, most prominently, Item 5.07 which details the official vote tallies on shareholder proposals at the Annual Meeting. The inclusion of exact vote counts (for/against/abstain/broker non-votes) for each agenda item indicates that this is a declaration of voting results. Accordingly, it best fits the “Declaration of Voting Results & Voting Rights Announcements (Code: DVA).”
2026-06-03 English
8-K - ORASURE TECHNOLOGIES INC (0001116463) (Filer)
Regulatory Filings
2026-05-06 English
8-K - ORASURE TECHNOLOGIES INC (0001116463) (Filer)
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 16, 2026, by OraSure Technologies, Inc. It reports the entry into a material definitive agreement (a Cooperation Agreement) with Altai Capital Management, the appointment of a new director to the Board, and related governance changes. The content focuses on board and management changes, director appointments, and governance agreements. There are no financial statements or earnings data presented. The document is not an annual or quarterly report, nor an earnings release. It is not a proxy statement or voting results announcement. The primary subject is the appointment of a new director and related board changes, which fits the category of Board/Management Information (MANG). The document length (over 10,000 characters) and detailed disclosures confirm it is not a brief announcement or a report publication notice. Therefore, the appropriate classification is MANG with high confidence.
2026-04-17 English
4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)
Director's Dealing
2026-03-24 English
4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)
Director's Dealing
2026-03-24 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.